Status:
COMPLETED
A Drug-Drug Interaction Study of Furosemide and PA21
Lead Sponsor:
Vifor Pharma
Conditions:
Healthy
Eligibility:
All Genders
20-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine if Furosemide is affected by PA21.
Eligibility Criteria
Inclusion
- Healthy volunteers
- Written informed consent
Exclusion
- No significant medical conditions
- Pregnancy
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01438359
Start Date
July 1 2011
End Date
September 1 2011
Last Update
September 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ACRI - Phase 1
Anaheim, California, United States, 92801